Perpetuum Ventures

Foundation date

18/01/2018

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

PIONEERING PLANT SCIENCE.

Perpetuum is a biotech company that develops safe, sustainable plant-based therapeutics for the effective management and improvement of healthspan of people.

Our company focuses on four R&D platforms:

  • Plant cell extraction

  • Transient expression of recombinant proteins in plants

  • Dendritic nano adjuvants

  • Biopolymer scaffolds

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    Monday August 8th 2022

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022